CBIO Catalyst Biosciences, Inc. gains 21% Jan 30, 2018

Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders. http://www.priceseries.com/trade/CBIO-Catalyst-Biosciences-Inc--stock-gains-21-percent-a-Trade-Record-by-priceSeries-2018011720180130.html